nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—Quinidine—malaria	0.0561	0.0838	CbGbCtD
Gefitinib—CYP1A1—Quinine—malaria	0.0359	0.0537	CbGbCtD
Gefitinib—CYP3A5—Artemether—malaria	0.0356	0.0532	CbGbCtD
Gefitinib—CYP1A1—Quinidine—malaria	0.0316	0.0472	CbGbCtD
Gefitinib—CYP2C19—Artemether—malaria	0.0287	0.0429	CbGbCtD
Gefitinib—CYP3A4—Clindamycin—malaria	0.0284	0.0425	CbGbCtD
Gefitinib—CYP2C9—Sulfadiazine—malaria	0.0281	0.042	CbGbCtD
Gefitinib—CYP2C9—Pyrimethamine—malaria	0.0281	0.042	CbGbCtD
Gefitinib—CYP2C19—Proguanil—malaria	0.027	0.0404	CbGbCtD
Gefitinib—CYP2D6—Pyrimethamine—malaria	0.0257	0.0384	CbGbCtD
Gefitinib—CYP2C9—Artemether—malaria	0.0239	0.0357	CbGbCtD
Gefitinib—CYP2C9—Proguanil—malaria	0.0225	0.0336	CbGbCtD
Gefitinib—CYP2D6—Artemether—malaria	0.0218	0.0326	CbGbCtD
Gefitinib—CYP3A5—Quinine—malaria	0.0216	0.0322	CbGbCtD
Gefitinib—CYP2D6—Proguanil—malaria	0.0205	0.0307	CbGbCtD
Gefitinib—CYP2D6—Quinidine barbiturate—malaria	0.0195	0.0291	CbGbCtD
Gefitinib—CYP2C19—Quinine—malaria	0.0174	0.026	CbGbCtD
Gefitinib—CYP3A5—Dapsone—malaria	0.0164	0.0244	CbGbCtD
Gefitinib—CYP3A4—Sulfadiazine—malaria	0.0163	0.0244	CbGbCtD
Gefitinib—CYP2C9—Quinine—malaria	0.0145	0.0216	CbGbCtD
Gefitinib—ABCB1—Quinine—malaria	0.014	0.021	CbGbCtD
Gefitinib—CYP3A4—Artemether—malaria	0.0139	0.0208	CbGbCtD
Gefitinib—CYP2D6—Quinine—malaria	0.0132	0.0198	CbGbCtD
Gefitinib—CYP2C19—Dapsone—malaria	0.0132	0.0197	CbGbCtD
Gefitinib—CYP3A4—Proguanil—malaria	0.0131	0.0195	CbGbCtD
Gefitinib—CYP2C9—Quinidine—malaria	0.0127	0.019	CbGbCtD
Gefitinib—CYP3A4—Doxycycline—malaria	0.0124	0.0185	CbGbCtD
Gefitinib—ABCB1—Quinidine—malaria	0.0123	0.0184	CbGbCtD
Gefitinib—CYP2D6—Quinidine—malaria	0.0116	0.0174	CbGbCtD
Gefitinib—CYP2C9—Dapsone—malaria	0.011	0.0164	CbGbCtD
Gefitinib—CYP3A4—Quinine—malaria	0.00841	0.0126	CbGbCtD
Gefitinib—CYP3A4—Quinidine—malaria	0.00739	0.011	CbGbCtD
Gefitinib—Necrolysis epidermal—Sulfadiazine—malaria	0.00667	0.0444	CcSEcCtD
Gefitinib—CYP3A4—Dapsone—malaria	0.00638	0.00953	CbGbCtD
Gefitinib—ORM1—saliva—malaria	0.00427	0.0432	CbGeAlD
Gefitinib—Cutaneous vasculitis—Quinidine—malaria	0.00424	0.0282	CcSEcCtD
Gefitinib—Cutaneous vasculitis—Quinine—malaria	0.00424	0.0282	CcSEcCtD
Gefitinib—Cutaneous vasculitis—Quinidine barbiturate—malaria	0.00382	0.0255	CcSEcCtD
Gefitinib—STK10—blood plasma—malaria	0.00256	0.0259	CbGeAlD
Gefitinib—Eruption—Sulfadiazine—malaria	0.00246	0.0164	CcSEcCtD
Gefitinib—SBK1—blood—malaria	0.00228	0.023	CbGeAlD
Gefitinib—Vesiculobullous rash—Clindamycin—malaria	0.00201	0.0134	CcSEcCtD
Gefitinib—CSNK1E—saliva-secreting gland—malaria	0.00199	0.0201	CbGeAlD
Gefitinib—CHEK2—blood—malaria	0.00198	0.0201	CbGeAlD
Gefitinib—IRAK4—saliva-secreting gland—malaria	0.00196	0.0198	CbGeAlD
Gefitinib—CHEK2—bone marrow—malaria	0.00192	0.0194	CbGeAlD
Gefitinib—ERBB3—saliva-secreting gland—malaria	0.00192	0.0194	CbGeAlD
Gefitinib—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00191	0.0127	CcSEcCtD
Gefitinib—IRAK4—hematopoietic system—malaria	0.00187	0.0189	CbGeAlD
Gefitinib—ERBB3—hematopoietic system—malaria	0.00183	0.0185	CbGeAlD
Gefitinib—MKNK2—saliva-secreting gland—malaria	0.00183	0.0185	CbGeAlD
Gefitinib—MKNK2—hematopoietic system—malaria	0.00174	0.0176	CbGeAlD
Gefitinib—IRAK1—hematopoietic system—malaria	0.00174	0.0176	CbGeAlD
Gefitinib—MKNK1—hematopoietic system—malaria	0.00172	0.0174	CbGeAlD
Gefitinib—Seborrhoeic dermatitis—Clindamycin—malaria	0.00165	0.011	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00162	0.0108	CcSEcCtD
Gefitinib—Hypoxia—Quinidine barbiturate—malaria	0.00157	0.0105	CcSEcCtD
Gefitinib—Haematuria—Pyrimethamine—malaria	0.00156	0.0104	CcSEcCtD
Gefitinib—ERBB3—kidney—malaria	0.0015	0.0152	CbGeAlD
Gefitinib—Vandetanib—KDR—malaria	0.00144	1	CrCbGaD
Gefitinib—STK10—hematopoietic system—malaria	0.00142	0.0143	CbGeAlD
Gefitinib—Rash pustular—Clindamycin—malaria	0.00141	0.00941	CcSEcCtD
Gefitinib—SBK1—brain—malaria	0.00141	0.0143	CbGeAlD
Gefitinib—HIPK4—brain—malaria	0.0014	0.0141	CbGeAlD
Gefitinib—Erythema multiforme—Pyrimethamine—malaria	0.00139	0.00926	CcSEcCtD
Gefitinib—Acne—Clindamycin—malaria	0.00134	0.00892	CcSEcCtD
Gefitinib—Proteinuria—Dapsone—malaria	0.00133	0.00883	CcSEcCtD
Gefitinib—MAP2K5—saliva-secreting gland—malaria	0.00133	0.0134	CbGeAlD
Gefitinib—CSNK1E—digestive system—malaria	0.00132	0.0134	CbGeAlD
Gefitinib—CYP2C19—blood plasma—malaria	0.00131	0.0133	CbGeAlD
Gefitinib—Protein urine present—Dapsone—malaria	0.00131	0.00871	CcSEcCtD
Gefitinib—Tenderness—Clindamycin—malaria	0.00129	0.0086	CcSEcCtD
Gefitinib—Proteinuria—Clindamycin—malaria	0.00128	0.00854	CcSEcCtD
Gefitinib—ERBB3—digestive system—malaria	0.00127	0.0129	CbGeAlD
Gefitinib—Protein urine present—Clindamycin—malaria	0.00127	0.00843	CcSEcCtD
Gefitinib—CSNK1E—blood—malaria	0.00126	0.0127	CbGeAlD
Gefitinib—Stomatitis—Proguanil—malaria	0.00124	0.00828	CcSEcCtD
Gefitinib—IRAK4—blood—malaria	0.00124	0.0125	CbGeAlD
Gefitinib—CHEK2—brain—malaria	0.00123	0.0125	CbGeAlD
Gefitinib—MKNK2—digestive system—malaria	0.00121	0.0123	CbGeAlD
Gefitinib—Hepatobiliary disease—Proguanil—malaria	0.00121	0.00803	CcSEcCtD
Gefitinib—IRAK4—bone marrow—malaria	0.0012	0.0121	CbGeAlD
Gefitinib—MKNK1—digestive system—malaria	0.0012	0.0121	CbGeAlD
Gefitinib—Ulcer—Clindamycin—malaria	0.00119	0.00794	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Sulfadiazine—malaria	0.00116	0.00776	CcSEcCtD
Gefitinib—STK10—kidney—malaria	0.00116	0.0117	CbGeAlD
Gefitinib—MKNK2—blood—malaria	0.00115	0.0117	CbGeAlD
Gefitinib—IRAK1—blood—malaria	0.00115	0.0117	CbGeAlD
Gefitinib—MKNK1—blood—malaria	0.00114	0.0115	CbGeAlD
Gefitinib—MKNK2—bone marrow—malaria	0.00112	0.0113	CbGeAlD
Gefitinib—IRAK1—bone marrow—malaria	0.00112	0.0113	CbGeAlD
Gefitinib—EPHA6—brain—malaria	0.0011	0.0112	CbGeAlD
Gefitinib—MKNK1—bone marrow—malaria	0.0011	0.0112	CbGeAlD
Gefitinib—CYP3A5—blood plasma—malaria	0.00103	0.0105	CbGeAlD
Gefitinib—Mediastinal disorder—Proguanil—malaria	0.00103	0.00687	CcSEcCtD
Gefitinib—ORM1—hematopoietic system—malaria	0.00103	0.0104	CbGeAlD
Gefitinib—EGFR—liver—malaria	0.00102	0.0103	CbGeAlD
Gefitinib—Thrombocytopenia—Pyrimethamine—malaria	0.00102	0.00681	CcSEcCtD
Gefitinib—CYP2C9—blood plasma—malaria	0.00102	0.0103	CbGeAlD
Gefitinib—Respiratory failure—Quinidine barbiturate—malaria	0.00102	0.00677	CcSEcCtD
Gefitinib—MAP3K19—brain—malaria	0.001	0.0102	CbGeAlD
Gefitinib—Malnutrition—Proguanil—malaria	0.000997	0.00664	CcSEcCtD
Gefitinib—Anorexia—Pyrimethamine—malaria	0.000996	0.00663	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00099	0.00659	CcSEcCtD
Gefitinib—STK10—digestive system—malaria	0.000985	0.00997	CbGeAlD
Gefitinib—CSNK1E—liver—malaria	0.000984	0.00995	CbGeAlD
Gefitinib—IRAK4—liver—malaria	0.000968	0.0098	CbGeAlD
Gefitinib—ERBB3—liver—malaria	0.000949	0.0096	CbGeAlD
Gefitinib—Thrombophlebitis—Clindamycin—malaria	0.000945	0.00629	CcSEcCtD
Gefitinib—STK10—blood—malaria	0.000939	0.00949	CbGeAlD
Gefitinib—Pancreatitis—Sulfadiazine—malaria	0.000931	0.0062	CcSEcCtD
Gefitinib—STK10—bone marrow—malaria	0.000908	0.00919	CbGeAlD
Gefitinib—Decreased appetite—Pyrimethamine—malaria	0.000908	0.00605	CcSEcCtD
Gefitinib—MKNK2—liver—malaria	0.000903	0.00913	CbGeAlD
Gefitinib—IRAK1—liver—malaria	0.000903	0.00913	CbGeAlD
Gefitinib—MKNK1—liver—malaria	0.000891	0.00902	CbGeAlD
Gefitinib—Cough—Proguanil—malaria	0.00087	0.00579	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Clindamycin—malaria	0.000867	0.00577	CcSEcCtD
Gefitinib—Dermatitis bullous—Clindamycin—malaria	0.000856	0.0057	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Quinidine—malaria	0.000851	0.00567	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Quinine—malaria	0.000851	0.00567	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000843	0.00561	CcSEcCtD
Gefitinib—Dermatitis bullous—Quinidine—malaria	0.00084	0.00559	CcSEcCtD
Gefitinib—Dermatitis bullous—Quinine—malaria	0.00084	0.00559	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00084	0.00559	CcSEcCtD
Gefitinib—MAP2K5—blood—malaria	0.000838	0.00848	CbGeAlD
Gefitinib—Stomatitis—Sulfadiazine—malaria	0.000826	0.0055	CcSEcCtD
Gefitinib—EGFR—brain—malaria	0.000812	0.00821	CbGeAlD
Gefitinib—Nervous system disorder—Proguanil—malaria	0.000798	0.00531	CcSEcCtD
Gefitinib—Skin disorder—Proguanil—malaria	0.00079	0.00526	CcSEcCtD
Gefitinib—CSNK1E—brain—malaria	0.000781	0.0079	CbGeAlD
Gefitinib—Anorexia—Proguanil—malaria	0.000776	0.00516	CcSEcCtD
Gefitinib—CYP3A4—blood plasma—malaria	0.000775	0.00784	CbGeAlD
Gefitinib—Hypersensitivity—Pyrimethamine—malaria	0.00077	0.00512	CcSEcCtD
Gefitinib—IRAK4—brain—malaria	0.000768	0.00777	CbGeAlD
Gefitinib—Dermatitis exfoliative—Quinidine barbiturate—malaria	0.000768	0.00511	CcSEcCtD
Gefitinib—CYP2D6—blood plasma—malaria	0.000763	0.00772	CbGeAlD
Gefitinib—Hepatitis—Sulfadiazine—malaria	0.00076	0.00506	CcSEcCtD
Gefitinib—Dermatitis bullous—Quinidine barbiturate—malaria	0.000758	0.00505	CcSEcCtD
Gefitinib—ERBB3—brain—malaria	0.000753	0.00762	CbGeAlD
Gefitinib—Dry skin—Clindamycin—malaria	0.00075	0.00499	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Clindamycin—malaria	0.000737	0.00491	CcSEcCtD
Gefitinib—STK10—liver—malaria	0.000734	0.00742	CbGeAlD
Gefitinib—CYP2C19—hematopoietic system—malaria	0.000725	0.00734	CbGeAlD
Gefitinib—Toxic epidermal necrolysis—Quinine—malaria	0.000723	0.00481	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Quinidine—malaria	0.000723	0.00481	CcSEcCtD
Gefitinib—Erythema multiforme—Sulfadiazine—malaria	0.000719	0.00479	CcSEcCtD
Gefitinib—Pancreatitis—Dapsone—malaria	0.000717	0.00477	CcSEcCtD
Gefitinib—MKNK2—brain—malaria	0.000716	0.00724	CbGeAlD
Gefitinib—IRAK1—brain—malaria	0.000716	0.00724	CbGeAlD
Gefitinib—Decreased appetite—Proguanil—malaria	0.000707	0.00471	CcSEcCtD
Gefitinib—MKNK1—brain—malaria	0.000707	0.00715	CbGeAlD
Gefitinib—Gastrointestinal disorder—Proguanil—malaria	0.000703	0.00468	CcSEcCtD
Gefitinib—ORM1—blood—malaria	0.000681	0.00688	CbGeAlD
Gefitinib—Gastrointestinal pain—Proguanil—malaria	0.000665	0.00443	CcSEcCtD
Gefitinib—Vomiting—Pyrimethamine—malaria	0.000664	0.00442	CcSEcCtD
Gefitinib—ORM1—bone marrow—malaria	0.000658	0.00666	CbGeAlD
Gefitinib—MAP2K5—liver—malaria	0.000655	0.00663	CbGeAlD
Gefitinib—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.000653	0.00434	CcSEcCtD
Gefitinib—ABCG2—saliva-secreting gland—malaria	0.000645	0.00652	CbGeAlD
Gefitinib—Body temperature increased—Proguanil—malaria	0.000643	0.00428	CcSEcCtD
Gefitinib—Abdominal pain—Proguanil—malaria	0.000643	0.00428	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Clindamycin—malaria	0.000625	0.00416	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Quinine—malaria	0.000613	0.00408	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Quinidine—malaria	0.000613	0.00408	CcSEcCtD
Gefitinib—Epistaxis—Clindamycin—malaria	0.000595	0.00396	CcSEcCtD
Gefitinib—CYP1A1—hematopoietic system—malaria	0.000584	0.00591	CbGeAlD
Gefitinib—STK10—brain—malaria	0.000582	0.00589	CbGeAlD
Gefitinib—CYP3A5—hematopoietic system—malaria	0.000571	0.00578	CbGeAlD
Gefitinib—CYP2C9—hematopoietic system—malaria	0.000562	0.00569	CbGeAlD
Gefitinib—Haemoglobin—Quinine—malaria	0.000558	0.00372	CcSEcCtD
Gefitinib—Haemoglobin—Quinidine—malaria	0.000558	0.00372	CcSEcCtD
Gefitinib—Infestation—Pentoxifylline—malaria	0.000557	0.00371	CcSEcCtD
Gefitinib—Infestation NOS—Pentoxifylline—malaria	0.000557	0.00371	CcSEcCtD
Gefitinib—Diarrhoea—Proguanil—malaria	0.000557	0.00371	CcSEcCtD
Gefitinib—Haemorrhage—Quinine—malaria	0.000555	0.0037	CcSEcCtD
Gefitinib—Hepatitis—Quinine—malaria	0.000555	0.0037	CcSEcCtD
Gefitinib—Haemorrhage—Quinidine—malaria	0.000555	0.0037	CcSEcCtD
Gefitinib—Hepatitis—Quinidine—malaria	0.000555	0.0037	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000554	0.00369	CcSEcCtD
Gefitinib—ABCB1—blood plasma—malaria	0.000549	0.00555	CbGeAlD
Gefitinib—Urinary tract disorder—Quinidine—malaria	0.000549	0.00365	CcSEcCtD
Gefitinib—Urinary tract disorder—Quinine—malaria	0.000549	0.00365	CcSEcCtD
Gefitinib—Urethral disorder—Quinine—malaria	0.000544	0.00363	CcSEcCtD
Gefitinib—Urethral disorder—Quinidine—malaria	0.000544	0.00363	CcSEcCtD
Gefitinib—Conjunctivitis—Pentoxifylline—malaria	0.000542	0.00361	CcSEcCtD
Gefitinib—Erythema multiforme—Clindamycin—malaria	0.000535	0.00356	CcSEcCtD
Gefitinib—ORM1—liver—malaria	0.000532	0.00538	CbGeAlD
Gefitinib—Thrombocytopenia—Sulfadiazine—malaria	0.000529	0.00352	CcSEcCtD
Gefitinib—Hepatobiliary disease—Pentoxifylline—malaria	0.000527	0.00351	CcSEcCtD
Gefitinib—Epistaxis—Pentoxifylline—malaria	0.000526	0.0035	CcSEcCtD
Gefitinib—Erythema multiforme—Quinine—malaria	0.000525	0.0035	CcSEcCtD
Gefitinib—Erythema multiforme—Quinidine—malaria	0.000525	0.0035	CcSEcCtD
Gefitinib—MAP2K5—brain—malaria	0.00052	0.00526	CbGeAlD
Gefitinib—Eye disorder—Quinine—malaria	0.000519	0.00346	CcSEcCtD
Gefitinib—Eye disorder—Quinidine—malaria	0.000519	0.00346	CcSEcCtD
Gefitinib—Vomiting—Proguanil—malaria	0.000517	0.00345	CcSEcCtD
Gefitinib—Cardiac disorder—Quinine—malaria	0.000516	0.00343	CcSEcCtD
Gefitinib—Cardiac disorder—Quinidine—malaria	0.000516	0.00343	CcSEcCtD
Gefitinib—Anorexia—Sulfadiazine—malaria	0.000515	0.00343	CcSEcCtD
Gefitinib—Rash—Proguanil—malaria	0.000513	0.00342	CcSEcCtD
Gefitinib—Dermatitis—Proguanil—malaria	0.000513	0.00341	CcSEcCtD
Gefitinib—CYP2C19—digestive system—malaria	0.000504	0.0051	CbGeAlD
Gefitinib—Haemoglobin—Quinidine barbiturate—malaria	0.000504	0.00335	CcSEcCtD
Gefitinib—Haemoglobin—Pentoxifylline—malaria	0.000503	0.00335	CcSEcCtD
Gefitinib—Haemorrhage—Quinidine barbiturate—malaria	0.000501	0.00334	CcSEcCtD
Gefitinib—Hepatitis—Quinidine barbiturate—malaria	0.000501	0.00334	CcSEcCtD
Gefitinib—Mediastinal disorder—Quinidine—malaria	0.000501	0.00333	CcSEcCtD
Gefitinib—Mediastinal disorder—Quinine—malaria	0.000501	0.00333	CcSEcCtD
Gefitinib—Haemorrhage—Pentoxifylline—malaria	0.0005	0.00333	CcSEcCtD
Gefitinib—Hepatitis—Pentoxifylline—malaria	0.0005	0.00333	CcSEcCtD
Gefitinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000495	0.0033	CcSEcCtD
Gefitinib—Urethral disorder—Quinidine barbiturate—malaria	0.000491	0.00327	CcSEcCtD
Gefitinib—Malnutrition—Quinine—malaria	0.000484	0.00322	CcSEcCtD
Gefitinib—Malnutrition—Quinidine—malaria	0.000484	0.00322	CcSEcCtD
Gefitinib—Nausea—Proguanil—malaria	0.000483	0.00322	CcSEcCtD
Gefitinib—CYP2C19—blood—malaria	0.00048	0.00486	CbGeAlD
Gefitinib—CYP1A1—kidney—malaria	0.000479	0.00484	CbGeAlD
Gefitinib—Erythema multiforme—Quinidine barbiturate—malaria	0.000474	0.00316	CcSEcCtD
Gefitinib—Decreased appetite—Sulfadiazine—malaria	0.00047	0.00313	CcSEcCtD
Gefitinib—Eye disorder—Quinidine barbiturate—malaria	0.000468	0.00312	CcSEcCtD
Gefitinib—CYP3A5—kidney—malaria	0.000468	0.00474	CbGeAlD
Gefitinib—ALB—liver—malaria	0.000467	0.00472	CbGeAlD
Gefitinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000466	0.00311	CcSEcCtD
Gefitinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000465	0.0031	CcSEcCtD
Gefitinib—Anaemia—Clindamycin—malaria	0.000456	0.00303	CcSEcCtD
Gefitinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000452	0.00301	CcSEcCtD
Gefitinib—Arrhythmia—Pentoxifylline—malaria	0.000447	0.00298	CcSEcCtD
Gefitinib—Cough—Dapsone—malaria	0.000445	0.00296	CcSEcCtD
Gefitinib—Angioedema—Quinidine—malaria	0.000442	0.00294	CcSEcCtD
Gefitinib—Angioedema—Quinine—malaria	0.000442	0.00294	CcSEcCtD
Gefitinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000442	0.00294	CcSEcCtD
Gefitinib—Malnutrition—Quinidine barbiturate—malaria	0.000436	0.00291	CcSEcCtD
Gefitinib—Urticaria—Sulfadiazine—malaria	0.000429	0.00286	CcSEcCtD
Gefitinib—CYP3A4—hematopoietic system—malaria	0.000429	0.00434	CbGeAlD
Gefitinib—Abdominal pain—Sulfadiazine—malaria	0.000427	0.00284	CcSEcCtD
Gefitinib—Body temperature increased—Sulfadiazine—malaria	0.000427	0.00284	CcSEcCtD
Gefitinib—CYP2D6—hematopoietic system—malaria	0.000422	0.00427	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000409	0.00272	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000409	0.00272	CcSEcCtD
Gefitinib—ABCG2—blood—malaria	0.000408	0.00412	CbGeAlD
Gefitinib—CYP1A1—digestive system—malaria	0.000406	0.00411	CbGeAlD
Gefitinib—Anaemia—Pentoxifylline—malaria	0.000403	0.00268	CcSEcCtD
Gefitinib—Angioedema—Quinidine barbiturate—malaria	0.000399	0.00265	CcSEcCtD
Gefitinib—Angioedema—Pentoxifylline—malaria	0.000398	0.00265	CcSEcCtD
Gefitinib—Hypersensitivity—Sulfadiazine—malaria	0.000398	0.00265	CcSEcCtD
Gefitinib—CYP3A5—digestive system—malaria	0.000397	0.00402	CbGeAlD
Gefitinib—ABCG2—bone marrow—malaria	0.000395	0.00399	CbGeAlD
Gefitinib—Thrombocytopenia—Clindamycin—malaria	0.000394	0.00262	CcSEcCtD
Gefitinib—Malaise—Pentoxifylline—malaria	0.000393	0.00262	CcSEcCtD
Gefitinib—CYP2C9—digestive system—malaria	0.000391	0.00396	CbGeAlD
Gefitinib—Shock—Quinine—malaria	0.000388	0.00258	CcSEcCtD
Gefitinib—Shock—Quinidine—malaria	0.000388	0.00258	CcSEcCtD
Gefitinib—CYP1A1—blood—malaria	0.000387	0.00392	CbGeAlD
Gefitinib—Nervous system disorder—Quinine—malaria	0.000387	0.00258	CcSEcCtD
Gefitinib—Nervous system disorder—Quinidine—malaria	0.000387	0.00258	CcSEcCtD
Gefitinib—Thrombocytopenia—Quinine—malaria	0.000386	0.00257	CcSEcCtD
Gefitinib—Thrombocytopenia—Quinidine—malaria	0.000386	0.00257	CcSEcCtD
Gefitinib—Skin disorder—Quinidine—malaria	0.000383	0.00255	CcSEcCtD
Gefitinib—Skin disorder—Quinine—malaria	0.000383	0.00255	CcSEcCtD
Gefitinib—Pruritus—Sulfadiazine—malaria	0.000382	0.00254	CcSEcCtD
Gefitinib—CYP3A5—blood—malaria	0.000378	0.00383	CbGeAlD
Gefitinib—Anorexia—Quinine—malaria	0.000376	0.0025	CcSEcCtD
Gefitinib—Anorexia—Quinidine—malaria	0.000376	0.0025	CcSEcCtD
Gefitinib—Hypotension—Clindamycin—malaria	0.000376	0.0025	CcSEcCtD
Gefitinib—CYP2C19—liver—malaria	0.000376	0.0038	CbGeAlD
Gefitinib—CYP2C9—blood—malaria	0.000373	0.00377	CbGeAlD
Gefitinib—ALB—brain—malaria	0.00037	0.00375	CbGeAlD
Gefitinib—Diarrhoea—Sulfadiazine—malaria	0.00037	0.00246	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000369	0.00246	CcSEcCtD
Gefitinib—Hypotension—Quinine—malaria	0.000369	0.00246	CcSEcCtD
Gefitinib—Hypotension—Quinidine—malaria	0.000369	0.00246	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000368	0.00245	CcSEcCtD
Gefitinib—Dry mouth—Pentoxifylline—malaria	0.000363	0.00241	CcSEcCtD
Gefitinib—Dyspnoea—Clindamycin—malaria	0.000359	0.00239	CcSEcCtD
Gefitinib—Infection—Pentoxifylline—malaria	0.000353	0.00235	CcSEcCtD
Gefitinib—Dyspnoea—Quinidine—malaria	0.000352	0.00234	CcSEcCtD
Gefitinib—Dyspnoea—Quinine—malaria	0.000352	0.00234	CcSEcCtD
Gefitinib—CYP3A4—kidney—malaria	0.000351	0.00355	CbGeAlD
Gefitinib—Shock—Quinidine barbiturate—malaria	0.00035	0.00233	CcSEcCtD
Gefitinib—Shock—Pentoxifylline—malaria	0.00035	0.00233	CcSEcCtD
Gefitinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000349	0.00233	CcSEcCtD
Gefitinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000349	0.00232	CcSEcCtD
Gefitinib—Thrombocytopenia—Pentoxifylline—malaria	0.000348	0.00232	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Clindamycin—malaria	0.000347	0.00231	CcSEcCtD
Gefitinib—Fatigue—Clindamycin—malaria	0.000347	0.00231	CcSEcCtD
Gefitinib—Skin disorder—Quinidine barbiturate—malaria	0.000346	0.0023	CcSEcCtD
Gefitinib—CYP2D6—kidney—malaria	0.000346	0.0035	CbGeAlD
Gefitinib—Skin disorder—Pentoxifylline—malaria	0.000345	0.0023	CcSEcCtD
Gefitinib—Constipation—Clindamycin—malaria	0.000344	0.00229	CcSEcCtD
Gefitinib—Pain—Clindamycin—malaria	0.000344	0.00229	CcSEcCtD
Gefitinib—Vomiting—Sulfadiazine—malaria	0.000343	0.00229	CcSEcCtD
Gefitinib—Decreased appetite—Quinine—malaria	0.000343	0.00228	CcSEcCtD
Gefitinib—Decreased appetite—Quinidine—malaria	0.000343	0.00228	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Quinidine—malaria	0.000341	0.00227	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Quinine—malaria	0.000341	0.00227	CcSEcCtD
Gefitinib—Rash—Sulfadiazine—malaria	0.000341	0.00227	CcSEcCtD
Gefitinib—Dermatitis—Sulfadiazine—malaria	0.00034	0.00227	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dapsone—malaria	0.00034	0.00226	CcSEcCtD
Gefitinib—Anorexia—Quinidine barbiturate—malaria	0.000339	0.00226	CcSEcCtD
Gefitinib—Anorexia—Pentoxifylline—malaria	0.000339	0.00226	CcSEcCtD
Gefitinib—Hypotension—Quinidine barbiturate—malaria	0.000333	0.00222	CcSEcCtD
Gefitinib—Hypotension—Pentoxifylline—malaria	0.000332	0.00221	CcSEcCtD
Gefitinib—Gastrointestinal pain—Clindamycin—malaria	0.000329	0.00219	CcSEcCtD
Gefitinib—Abdominal pain—Dapsone—malaria	0.000329	0.00219	CcSEcCtD
Gefitinib—Body temperature increased—Dapsone—malaria	0.000329	0.00219	CcSEcCtD
Gefitinib—Gastrointestinal pain—Quinine—malaria	0.000323	0.00215	CcSEcCtD
Gefitinib—Gastrointestinal pain—Quinidine—malaria	0.000323	0.00215	CcSEcCtD
Gefitinib—Nausea—Sulfadiazine—malaria	0.000321	0.00214	CcSEcCtD
Gefitinib—Urticaria—Clindamycin—malaria	0.00032	0.00213	CcSEcCtD
Gefitinib—ABCG2—liver—malaria	0.000319	0.00323	CbGeAlD
Gefitinib—Abdominal pain—Clindamycin—malaria	0.000318	0.00212	CcSEcCtD
Gefitinib—Body temperature increased—Clindamycin—malaria	0.000318	0.00212	CcSEcCtD
Gefitinib—Dyspnoea—Quinidine barbiturate—malaria	0.000318	0.00211	CcSEcCtD
Gefitinib—Dyspnoea—Pentoxifylline—malaria	0.000317	0.00211	CcSEcCtD
Gefitinib—Urticaria—Quinine—malaria	0.000314	0.00209	CcSEcCtD
Gefitinib—Urticaria—Quinidine—malaria	0.000314	0.00209	CcSEcCtD
Gefitinib—Abdominal pain—Quinine—malaria	0.000312	0.00208	CcSEcCtD
Gefitinib—Body temperature increased—Quinidine—malaria	0.000312	0.00208	CcSEcCtD
Gefitinib—Body temperature increased—Quinine—malaria	0.000312	0.00208	CcSEcCtD
Gefitinib—Abdominal pain—Quinidine—malaria	0.000312	0.00208	CcSEcCtD
Gefitinib—Decreased appetite—Quinidine barbiturate—malaria	0.00031	0.00206	CcSEcCtD
Gefitinib—Decreased appetite—Pentoxifylline—malaria	0.000309	0.00206	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000307	0.00205	CcSEcCtD
Gefitinib—Constipation—Quinidine barbiturate—malaria	0.000305	0.00203	CcSEcCtD
Gefitinib—Pain—Quinidine barbiturate—malaria	0.000305	0.00203	CcSEcCtD
Gefitinib—Constipation—Pentoxifylline—malaria	0.000304	0.00202	CcSEcCtD
Gefitinib—ABCB1—hematopoietic system—malaria	0.000303	0.00307	CbGeAlD
Gefitinib—CYP1A1—liver—malaria	0.000303	0.00306	CbGeAlD
Gefitinib—CYP3A4—digestive system—malaria	0.000298	0.00302	CbGeAlD
Gefitinib—Hypersensitivity—Clindamycin—malaria	0.000296	0.00197	CcSEcCtD
Gefitinib—CYP3A5—liver—malaria	0.000296	0.00299	CbGeAlD
Gefitinib—CYP2D6—digestive system—malaria	0.000293	0.00297	CbGeAlD
Gefitinib—CYP2C9—liver—malaria	0.000291	0.00295	CbGeAlD
Gefitinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000291	0.00194	CcSEcCtD
Gefitinib—Hypersensitivity—Quinidine—malaria	0.000291	0.00194	CcSEcCtD
Gefitinib—Hypersensitivity—Quinine—malaria	0.000291	0.00194	CcSEcCtD
Gefitinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000291	0.00194	CcSEcCtD
Gefitinib—Asthenia—Clindamycin—malaria	0.000289	0.00192	CcSEcCtD
Gefitinib—Pruritus—Clindamycin—malaria	0.000285	0.00189	CcSEcCtD
Gefitinib—CYP3A4—blood—malaria	0.000284	0.00287	CbGeAlD
Gefitinib—Asthenia—Quinidine—malaria	0.000283	0.00189	CcSEcCtD
Gefitinib—Asthenia—Quinine—malaria	0.000283	0.00189	CcSEcCtD
Gefitinib—Urticaria—Quinidine barbiturate—malaria	0.000283	0.00188	CcSEcCtD
Gefitinib—Urticaria—Pentoxifylline—malaria	0.000282	0.00188	CcSEcCtD
Gefitinib—Body temperature increased—Quinidine barbiturate—malaria	0.000282	0.00187	CcSEcCtD
Gefitinib—Abdominal pain—Quinidine barbiturate—malaria	0.000282	0.00187	CcSEcCtD
Gefitinib—Abdominal pain—Pentoxifylline—malaria	0.000281	0.00187	CcSEcCtD
Gefitinib—Body temperature increased—Pentoxifylline—malaria	0.000281	0.00187	CcSEcCtD
Gefitinib—CYP2D6—blood—malaria	0.00028	0.00283	CbGeAlD
Gefitinib—Pruritus—Quinidine—malaria	0.000279	0.00186	CcSEcCtD
Gefitinib—Pruritus—Quinine—malaria	0.000279	0.00186	CcSEcCtD
Gefitinib—Diarrhoea—Clindamycin—malaria	0.000275	0.00183	CcSEcCtD
Gefitinib—Diarrhoea—Quinine—malaria	0.00027	0.0018	CcSEcCtD
Gefitinib—Diarrhoea—Quinidine—malaria	0.00027	0.0018	CcSEcCtD
Gefitinib—Vomiting—Dapsone—malaria	0.000264	0.00176	CcSEcCtD
Gefitinib—Hypersensitivity—Quinidine barbiturate—malaria	0.000262	0.00175	CcSEcCtD
Gefitinib—Hypersensitivity—Pentoxifylline—malaria	0.000262	0.00174	CcSEcCtD
Gefitinib—Vomiting—Clindamycin—malaria	0.000256	0.0017	CcSEcCtD
Gefitinib—Asthenia—Quinidine barbiturate—malaria	0.000256	0.0017	CcSEcCtD
Gefitinib—Asthenia—Pentoxifylline—malaria	0.000255	0.0017	CcSEcCtD
Gefitinib—Rash—Clindamycin—malaria	0.000254	0.00169	CcSEcCtD
Gefitinib—Dermatitis—Clindamycin—malaria	0.000253	0.00169	CcSEcCtD
Gefitinib—ABCG2—brain—malaria	0.000253	0.00256	CbGeAlD
Gefitinib—Pruritus—Quinidine barbiturate—malaria	0.000252	0.00168	CcSEcCtD
Gefitinib—Pruritus—Pentoxifylline—malaria	0.000252	0.00167	CcSEcCtD
Gefitinib—Vomiting—Quinidine—malaria	0.000251	0.00167	CcSEcCtD
Gefitinib—Vomiting—Quinine—malaria	0.000251	0.00167	CcSEcCtD
Gefitinib—Rash—Quinidine—malaria	0.000249	0.00166	CcSEcCtD
Gefitinib—Rash—Quinine—malaria	0.000249	0.00166	CcSEcCtD
Gefitinib—ABCB1—kidney—malaria	0.000249	0.00252	CbGeAlD
Gefitinib—Dermatitis—Quinidine—malaria	0.000249	0.00166	CcSEcCtD
Gefitinib—Dermatitis—Quinine—malaria	0.000249	0.00166	CcSEcCtD
Gefitinib—Nausea—Dapsone—malaria	0.000247	0.00164	CcSEcCtD
Gefitinib—Diarrhoea—Quinidine barbiturate—malaria	0.000244	0.00162	CcSEcCtD
Gefitinib—Diarrhoea—Pentoxifylline—malaria	0.000243	0.00162	CcSEcCtD
Gefitinib—CYP1A1—brain—malaria	0.00024	0.00243	CbGeAlD
Gefitinib—Nausea—Clindamycin—malaria	0.000239	0.00159	CcSEcCtD
Gefitinib—Nausea—Quinidine—malaria	0.000234	0.00156	CcSEcCtD
Gefitinib—Nausea—Quinine—malaria	0.000234	0.00156	CcSEcCtD
Gefitinib—Vomiting—Quinidine barbiturate—malaria	0.000226	0.00151	CcSEcCtD
Gefitinib—Vomiting—Pentoxifylline—malaria	0.000226	0.0015	CcSEcCtD
Gefitinib—Rash—Quinidine barbiturate—malaria	0.000225	0.0015	CcSEcCtD
Gefitinib—Dermatitis—Quinidine barbiturate—malaria	0.000224	0.00149	CcSEcCtD
Gefitinib—Rash—Pentoxifylline—malaria	0.000224	0.00149	CcSEcCtD
Gefitinib—Dermatitis—Pentoxifylline—malaria	0.000224	0.00149	CcSEcCtD
Gefitinib—CYP3A4—liver—malaria	0.000222	0.00225	CbGeAlD
Gefitinib—CYP2D6—liver—malaria	0.000219	0.00221	CbGeAlD
Gefitinib—Nausea—Quinidine barbiturate—malaria	0.000212	0.00141	CcSEcCtD
Gefitinib—Nausea—Pentoxifylline—malaria	0.000211	0.00141	CcSEcCtD
Gefitinib—ABCB1—digestive system—malaria	0.000211	0.00213	CbGeAlD
Gefitinib—ABCB1—blood—malaria	0.000201	0.00203	CbGeAlD
Gefitinib—ABCB1—bone marrow—malaria	0.000195	0.00197	CbGeAlD
Gefitinib—CYP2D6—brain—malaria	0.000173	0.00175	CbGeAlD
Gefitinib—ABCB1—liver—malaria	0.000157	0.00159	CbGeAlD
Gefitinib—ABCB1—brain—malaria	0.000125	0.00126	CbGeAlD
Gefitinib—IRAK4—Immune System—HLA-B—malaria	4.18e-05	0.00052	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TNF—malaria	4.16e-05	0.000517	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—DECR1—malaria	4.15e-05	0.000517	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—IL6—malaria	4.13e-05	0.000514	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—IL6—malaria	4.12e-05	0.000513	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD36—malaria	4.09e-05	0.00051	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—TLR4—malaria	4.03e-05	0.000502	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—TNF—malaria	4.03e-05	0.000501	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR9—malaria	3.94e-05	0.000491	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—CD36—malaria	3.87e-05	0.000482	CbGpPWpGaD
Gefitinib—EGFR—Disease—G6PD—malaria	3.82e-05	0.000475	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TLR9—malaria	3.81e-05	0.000475	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—HBB—malaria	3.76e-05	0.000468	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DHODH—malaria	3.72e-05	0.000463	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CRP—malaria	3.69e-05	0.000459	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.67e-05	0.000456	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—IL6—malaria	3.66e-05	0.000455	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—TLR4—malaria	3.54e-05	0.00044	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CD36—malaria	3.53e-05	0.00044	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DHODH—malaria	3.52e-05	0.000438	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL18—malaria	3.51e-05	0.000437	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD40LG—malaria	3.5e-05	0.000436	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD8A—malaria	3.46e-05	0.000431	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.46e-05	0.000431	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TNF—malaria	3.42e-05	0.000425	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CD4—malaria	3.41e-05	0.000425	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—ICAM1—malaria	3.39e-05	0.000422	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—IL6—malaria	3.36e-05	0.000418	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—IL6—malaria	3.35e-05	0.000417	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PKLR—malaria	3.35e-05	0.000417	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-B—malaria	3.33e-05	0.000414	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—TNF—malaria	3.3e-05	0.000411	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD4—malaria	3.28e-05	0.000408	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD36—malaria	3.26e-05	0.000406	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—IL6—malaria	3.25e-05	0.000405	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NOS2—malaria	3.25e-05	0.000405	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—IL6—malaria	3.24e-05	0.000403	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD40LG—malaria	3.21e-05	0.0004	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DHODH—malaria	3.21e-05	0.000399	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HLA-B—malaria	3.18e-05	0.000396	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.18e-05	0.000395	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD8A—malaria	3.18e-05	0.000395	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—IL6—malaria	3.17e-05	0.000395	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC4A1—malaria	3.17e-05	0.000394	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ACKR1—malaria	3.16e-05	0.000394	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.15e-05	0.000393	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FCGR2A—malaria	3.15e-05	0.000392	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TNF—malaria	3.15e-05	0.000392	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD36—malaria	3.12e-05	0.000388	CbGpPWpGaD
Gefitinib—MKNK1—Disease—CD4—malaria	3.1e-05	0.000385	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.08e-05	0.000384	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KDR—malaria	3.08e-05	0.000383	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-B—malaria	3.06e-05	0.00038	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—KDR—malaria	3.05e-05	0.00038	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—IL6—malaria	3.03e-05	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD36—malaria	3e-05	0.000373	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC4A1—malaria	2.99e-05	0.000372	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—IL6—malaria	2.99e-05	0.000372	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—G6PD—malaria	2.99e-05	0.000371	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DECR1—malaria	2.98e-05	0.00037	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CRP—malaria	2.94e-05	0.000366	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL18—malaria	2.92e-05	0.000364	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD40LG—malaria	2.91e-05	0.000363	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.9e-05	0.00036	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD8A—malaria	2.88e-05	0.000359	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DHODH—malaria	2.88e-05	0.000358	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—IL6—malaria	2.85e-05	0.000355	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CD4—malaria	2.84e-05	0.000354	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—IL6—malaria	2.84e-05	0.000353	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.83e-05	0.000352	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—IL6—malaria	2.82e-05	0.000352	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—TLR4—malaria	2.82e-05	0.000351	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CRP—malaria	2.81e-05	0.00035	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DECR1—malaria	2.81e-05	0.00035	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—IL6—malaria	2.81e-05	0.00035	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DHODH—malaria	2.81e-05	0.00035	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-B—malaria	2.77e-05	0.000345	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL6—malaria	2.74e-05	0.000341	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC4A1—malaria	2.73e-05	0.000339	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD36—malaria	2.72e-05	0.000338	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—ICAM1—malaria	2.7e-05	0.000337	CbGpPWpGaD
Gefitinib—EGFR—Disease—DHFR—malaria	2.7e-05	0.000336	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—TLR4—malaria	2.7e-05	0.000336	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—IL6—malaria	2.69e-05	0.000335	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HBB—malaria	2.69e-05	0.000335	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—IL6—malaria	2.66e-05	0.000332	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DHODH—malaria	2.65e-05	0.00033	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—IL6—malaria	2.64e-05	0.000329	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—IL6—malaria	2.64e-05	0.000329	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.64e-05	0.000329	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DHODH—malaria	2.62e-05	0.000327	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—IL6—malaria	2.62e-05	0.000326	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.6e-05	0.000324	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—IL6—malaria	2.6e-05	0.000323	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—IL6—malaria	2.59e-05	0.000322	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.58e-05	0.000321	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IFNG—malaria	2.58e-05	0.000321	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DECR1—malaria	2.56e-05	0.000319	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TLR9—malaria	2.55e-05	0.000317	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HBB—malaria	2.54e-05	0.000317	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD4—malaria	2.49e-05	0.00031	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ICAM1—malaria	2.48e-05	0.000309	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS2—malaria	2.48e-05	0.000308	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CRP—malaria	2.45e-05	0.000305	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC4A1—malaria	2.45e-05	0.000305	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CD4—malaria	2.41e-05	0.0003	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PKLR—malaria	2.4e-05	0.000299	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KDR—malaria	2.39e-05	0.000298	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC4A1—malaria	2.39e-05	0.000297	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.37e-05	0.000295	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TLR4—malaria	2.35e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.34e-05	0.000291	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HBB—malaria	2.32e-05	0.000289	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—IL6—malaria	2.31e-05	0.000288	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1B—malaria	2.3e-05	0.000287	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DECR1—malaria	2.3e-05	0.000286	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL2—malaria	2.29e-05	0.000285	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—HPGDS—malaria	2.28e-05	0.000283	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PKLR—malaria	2.27e-05	0.000282	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	2.26e-05	0.000282	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ICAM1—malaria	2.25e-05	0.00028	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC4A1—malaria	2.25e-05	0.00028	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DECR1—malaria	2.25e-05	0.00028	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC4A1—malaria	2.23e-05	0.000278	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IL2—malaria	2.17e-05	0.00027	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—G6PD—malaria	2.14e-05	0.000266	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DECR1—malaria	2.12e-05	0.000263	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—DHFR—malaria	2.11e-05	0.000263	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DECR1—malaria	2.1e-05	0.000261	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SCARB1—malaria	2.09e-05	0.00026	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HBB—malaria	2.08e-05	0.000259	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PKLR—malaria	2.07e-05	0.000257	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IFNG—malaria	2.06e-05	0.000256	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HBB—malaria	2.03e-05	0.000253	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—G6PD—malaria	2.02e-05	0.000251	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—CD36—malaria	2e-05	0.000248	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL2—malaria	2e-05	0.000248	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.99e-05	0.000248	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—malaria	1.99e-05	0.000247	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL18—malaria	1.96e-05	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40LG—malaria	1.95e-05	0.000242	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD8A—malaria	1.93e-05	0.00024	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HBB—malaria	1.91e-05	0.000238	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—malaria	1.9e-05	0.000236	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HBB—malaria	1.9e-05	0.000236	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KDR—malaria	1.89e-05	0.000235	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PKLR—malaria	1.86e-05	0.000231	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-B—malaria	1.85e-05	0.000231	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—malaria	1.85e-05	0.00023	CbGpPWpGaD
Gefitinib—ALB—Metabolism—G6PD—malaria	1.84e-05	0.000229	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—malaria	1.84e-05	0.000228	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—malaria	1.84e-05	0.000228	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—malaria	1.83e-05	0.000228	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—malaria	1.82e-05	0.000227	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KDR—malaria	1.82e-05	0.000227	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.82e-05	0.000226	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD36—malaria	1.82e-05	0.000226	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PKLR—malaria	1.81e-05	0.000225	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—malaria	1.8e-05	0.000224	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DHODH—malaria	1.73e-05	0.000215	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—malaria	1.71e-05	0.000213	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PKLR—malaria	1.71e-05	0.000212	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PKLR—malaria	1.69e-05	0.000211	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—malaria	1.67e-05	0.000208	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—malaria	1.65e-05	0.000206	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—G6PD—malaria	1.65e-05	0.000206	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—malaria	1.64e-05	0.000204	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—malaria	1.64e-05	0.000204	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	1.63e-05	0.000203	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HPGDS—malaria	1.63e-05	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—malaria	1.63e-05	0.000203	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—G6PD—malaria	1.61e-05	0.000201	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—malaria	1.57e-05	0.000195	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.56e-05	0.000194	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—malaria	1.55e-05	0.000193	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HPGDS—malaria	1.54e-05	0.000192	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—malaria	1.54e-05	0.000191	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—malaria	1.53e-05	0.00019	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—malaria	1.52e-05	0.000189	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—G6PD—malaria	1.52e-05	0.000189	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KDR—malaria	1.52e-05	0.000189	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DHFR—malaria	1.51e-05	0.000188	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—G6PD—malaria	1.51e-05	0.000188	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ICAM1—malaria	1.51e-05	0.000187	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SCARB1—malaria	1.5e-05	0.000186	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.49e-05	0.000185	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC4A1—malaria	1.47e-05	0.000183	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—malaria	1.44e-05	0.000179	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DHFR—malaria	1.43e-05	0.000178	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SCARB1—malaria	1.41e-05	0.000176	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HPGDS—malaria	1.4e-05	0.000175	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DECR1—malaria	1.38e-05	0.000172	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—malaria	1.38e-05	0.000172	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—malaria	1.35e-05	0.000168	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CD36—malaria	1.31e-05	0.000163	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DHFR—malaria	1.3e-05	0.000162	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—malaria	1.3e-05	0.000162	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SCARB1—malaria	1.29e-05	0.000161	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HPGDS—malaria	1.26e-05	0.000157	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HBB—malaria	1.25e-05	0.000156	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HPGDS—malaria	1.23e-05	0.000153	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—malaria	1.23e-05	0.000153	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—malaria	1.18e-05	0.000147	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—malaria	1.17e-05	0.000146	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DHFR—malaria	1.17e-05	0.000146	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—malaria	1.16e-05	0.000145	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HPGDS—malaria	1.16e-05	0.000144	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SCARB1—malaria	1.16e-05	0.000144	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HPGDS—malaria	1.15e-05	0.000143	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—malaria	1.15e-05	0.000143	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DHFR—malaria	1.14e-05	0.000142	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SCARB1—malaria	1.13e-05	0.000141	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—malaria	1.12e-05	0.000139	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PKLR—malaria	1.12e-05	0.000139	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—malaria	1.11e-05	0.000139	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—malaria	1.11e-05	0.000138	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DHFR—malaria	1.08e-05	0.000134	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—malaria	1.07e-05	0.000134	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DHFR—malaria	1.07e-05	0.000133	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SCARB1—malaria	1.06e-05	0.000133	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SCARB1—malaria	1.06e-05	0.000131	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—malaria	1.03e-05	0.000128	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—malaria	1.02e-05	0.000127	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—malaria	1.02e-05	0.000127	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—malaria	1.02e-05	0.000127	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KDR—malaria	1.02e-05	0.000126	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—G6PD—malaria	9.94e-06	0.000124	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—malaria	9.92e-06	0.000124	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—malaria	9.84e-06	0.000123	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CD36—malaria	9.4e-06	0.000117	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—malaria	9.12e-06	0.000114	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—malaria	8.95e-06	0.000111	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CD36—malaria	8.88e-06	0.00011	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CD36—malaria	8.09e-06	0.000101	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HPGDS—malaria	7.58e-06	9.44e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CD36—malaria	7.27e-06	9.04e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—malaria	7.21e-06	8.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CD36—malaria	7.09e-06	8.83e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DHFR—malaria	7.03e-06	8.76e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SCARB1—malaria	6.96e-06	8.66e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—malaria	6.95e-06	8.65e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CD36—malaria	6.68e-06	8.32e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CD36—malaria	6.63e-06	8.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—malaria	6.58e-06	8.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—malaria	6.55e-06	8.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—malaria	5.98e-06	7.45e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—malaria	5.79e-06	7.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—malaria	5.52e-06	6.88e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CD36—malaria	4.37e-06	5.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—malaria	3.87e-06	4.81e-05	CbGpPWpGaD
